bendamustine hydrochloride has been researched along with Stevens-Johnson Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fallon, MJ; Heck, JN | 1 |
Bighin, C; Del Mastro, L; Gardin, G; Giraudi, S; Lambertini, M; Levaggi, A; Pronzato, P | 1 |
2 other study(ies) available for bendamustine hydrochloride and Stevens-Johnson Syndrome
Article | Year |
---|---|
Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
Topics: Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Fatal Outcome; Humans; Lymphoma, B-Cell; Male; Rituximab; Stevens-Johnson Syndrome | 2015 |
Stevens-Johnson syndrome after treatment with bendamustine.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Female; Hepatitis C; Humans; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Stevens-Johnson Syndrome | 2012 |